Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RUNX1/CEBPA Mutation in Acute Myeloid Leukemia Promotes Hypermethylation and Indicates for Demethylation Therapy. | Int J Mol Sci | 2022 | 36232714 | PubTator, text mining | PubMed |
| Genomic Landscape of Mixed-Phenotype Acute Leukemia. | Int J Mol Sci | 2022 | 36232559 | PubTator, text mining | PubMed |
| RUNX Family in Hypoxic Microenvironment and Angiogenesis in Cancers. | Cells | 2022 | 36231060 | PubTator, text mining | PubMed |
| Molecular Mechanisms Driving the Formation of Brain Metastases. | Cancers (Basel) | 2022 | 36230886 | PubTator, text mining | PubMed |
| c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance. | Cell Death Dis | 2022 | 36229456 | PubTator, text mining | PubMed |
| LYL1 facilitates AETFC assembly and gene activation by recruiting CARM1 in t(8;21) AML. | Proc Natl Acad Sci U S A | 2022 | 36215477 | PubTator, text mining | PubMed |
| Lessons to cancer from studies of leukemia and hematopoiesis. | Front Cell Dev Biol | 2022 | 36204679 | PubTator, text mining | PubMed |
| Role of TET dioxygenases in the regulation of both normal and pathological hematopoiesis. | J Exp Clin Cancer Res | 2022 | 36203205 | PubTator, text mining | PubMed |
| CARM1-mediated methylation of ASXL2 impairs tumor-suppressive function of MLL3/COMPASS. | Sci Adv | 2022 | 36197977 | PubTator, text mining | PubMed |
| Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of Actinidia chinensis Planch. Root Extract for Application in Hepatocellular Carcinoma. | Evid Based Complement Alternat Med | 2022 | 36193154 | PubTator, text mining | PubMed |
| HOXA9 has the hallmarks of a biological switch with implications in blood cancers. | Nat Commun | 2022 | 36192425 | PubTator, text mining | PubMed |
| Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response. | Front Immunol | 2022 | 36189254 | PubTator, text mining | PubMed |
| A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases. | Front Mol Neurosci | 2022 | 36187346 | PubTator, text mining | PubMed |
| Role of ASXL1 in hematopoiesis and myeloid diseases. | Exp Hematol | 2022 | 36183966 | PubTator, text mining | PubMed |
| TLS/FUS-ERG fusion gene in acute leukemia and myelodysplastic syndrome evolved to acute leukemia: report of six cases and a literature review. | Ann Hematol | 2022 | 36181538 | PubTator, text mining | PubMed |
| BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes. | Cancer Biol Ther | 2022 | 36170346 | PubTator, text mining | PubMed |
| Broad genomic workup including optical genome mapping uncovers a DDX3X: MLLT10 gene fusion in acute myeloid leukemia. | Front Oncol | 2022 | 36158701 | PubTator, text mining | PubMed |
| Antibiotic and glucocorticoid-induced recapitulated hematological remission in acute myeloid leukemia: A case report and review of literature. | World J Clin Cases | 2022 | 36158489 | PubTator, text mining | PubMed |
| Acute myeloid leukemia with variant t(8;10;21). | Leuk Res Rep | 2022 | 36158314 | PubTator, text mining | PubMed |
| A direct comparison between AML1-ETO and ETO2-GLIS2 leukemia fusion proteins reveals context-dependent binding and regulation of target genes and opposite functions in cell differentiation. | Front Cell Dev Biol | 2022 | 36158200 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=30